Enzymic acylation of 506U78 (2‐amino‐9‐β‐D‐arabinofuranosyl‐6‐methoxy‐9 H‐purine), a powerful new anti‐leukaemic agent

A practical enzymic approach for acylation of 506U78 (2‐amino‐9‐β‐D‐arabinofuranosyl‐6‐methoxy‐9 H ‐purine), a powerful anti‐leukaemic agent, is described. Novozyme‐435, an immobilized preparation of Candida antarctica lipase, was used to acylate 506U78 regioselectively at the 5′‐position. This rend...

Full description

Bibliographic Details
Published in:Biotechnology and Applied Biochemistry
Main Authors: Mahmoudian, Mahmoud, Eaddy, John, Dawson, Mike
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 1999
Subjects:
Online Access:http://dx.doi.org/10.1111/j.1470-8744.1999.tb00554.x
https://iubmb.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1470-8744.1999.tb00554.x
Description
Summary:A practical enzymic approach for acylation of 506U78 (2‐amino‐9‐β‐D‐arabinofuranosyl‐6‐methoxy‐9 H ‐purine), a powerful anti‐leukaemic agent, is described. Novozyme‐435, an immobilized preparation of Candida antarctica lipase, was used to acylate 506U78 regioselectively at the 5′‐position. This rendered the compound more soluble and bioavailable. Vinyl acetate was used as the acyl donor and reactions were carried out in anhydrous 1,4‐dioxane with up to 100 g/l of substrate input. Bioconversions were optimised to achieve impurity (3′‐mono‐ and di‐acetates) levels of less than 0.5%.